Nampa Dialysis Center is a medicare approved dialysis facility center in Nampa, Idaho and it has 15 dialysis stations. It is located in Canyon county at 846 Parkcentre Way, Nampa, ID, 83651. You can reach out to the office of Nampa Dialysis Center at (208) 467-5180. This dialysis clinic is managed and/or owned by Davita. Nampa Dialysis Center has the following ownership type - Profit. It was first certified by medicare in October, 1989. The medicare id for this facility is 132501 and it accepts patients under medicare ESRD program.
Name | Nampa Dialysis Center |
---|---|
Location | 846 Parkcentre Way, Nampa, Idaho |
No. of Dialysis Stations | 15 |
Medicare ID | 132501 |
Managed By | Davita |
Ownership Type | Profit |
Late Shifts | No |
846 Parkcentre Way, Nampa, Idaho, 83651 | |
(208) 467-5180 | |
News Archive
A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.
Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.
Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
› Verified 6 days ago
NPI Number | 1225089915 |
Organization Name | Nampa Dialysis Center |
Doing Business As | Total Renal Care Inc |
Address | 846 Parkcentre Way Nampa, Idaho, 83651 |
Phone Number | (208) 467-5180 |
News Archive
A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.
Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.
Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
› Verified 6 days ago
NPI Number | 1992796171 |
Doing Business As | Saint Alphonsus Nephrology Center |
Address | 846 Parkcenter Way Nampa, Idaho, 83651 |
Phone Number | (208) 467-5180 |
News Archive
A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.
Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.
Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
› Verified 6 days ago
Dialysis patients with Hemoglobin data | 25 |
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 12 |
News Archive
A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.
Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.
Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 51 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 388 |
Percentage of adult patients getting regular hemodialysis at the center | 99 |
Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.
Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.
Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
› Verified 6 days ago
Adult patients getting regular peritoneal dialysis at the center | 23 |
Adult patient months included in Kt/V greater than or equal to 1.7 | 200 |
Percentage of adult patients getting regular peritoneal dialysis at the center | 97 |
Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.
Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.
Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Nampa Dialysis Center with elevated calcium levels.
Patients with hypercalcemia | 71 |
Hypercalcemia patient months | 603 |
Patients with Serumphosphor | 71 |
Patients with Serumphosphor less than 3.5 mg/dL | 10 |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 24 |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 31 |
Patients with Serumphosphor from 5.6 to 7 mg/dL | 20 |
Patients with Serumphosphor greater than 7 mg/dL | 15 |
News Archive
A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.
Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.
Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 49 |
Patient months included in arterial venous fistula and catheter summaries | 270 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 76 |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 5 |
News Archive
A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.
Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.
Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
Patients in facility's Hospitalization Summary | 60 |
Hospitalization Rate in facility | 168.1 (As Expected) |
Hospitalization Rate: Upper Confidence Limit | 305.2 |
Hospitalization Rate: Lower Confidence Limit | 96.5 |
News Archive
A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.
Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.
Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at Nampa Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
Readmission Rate in facility | 30.3 (As Expected) |
Readmission Rate: Upper Confidence Limit | 41.8 |
Readmission Rate: Lower Confidence Limit | 20.4 |
News Archive
A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.
Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.
Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
› Verified 6 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Nampa Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.
Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
Infection Rate in facility | 3.11 (Worse than Expected) |
SIR: Upper Confidence Limit | 6.14 |
SIR: Lower Confidence Limit | 1.36 |
News Archive
A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.
Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.
Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Nampa Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
Patients in facility's Transfusion Summary | 58 |
Transfusion Rate in facility | 15.4 (As Expected) |
Transfusion Rate: Upper Confidence Limit | 74.9 |
Transfusion Rate: Lower Confidence Limit | 3.9 |
News Archive
A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.
Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.
Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at Nampa Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
Patients in facility's Survival Summary | 261 |
Mortality Rate in facility | 21.9 (As Expected) |
Mortality Rate: Upper Confidence Limit | 30.5 |
Mortality Rate: Lower Confidence Limit | 15.3 |
News Archive
A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.
Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.
Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
› Verified 6 days ago
News Archive
A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.
Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.
Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
› Verified 6 days ago